155 related articles for article (PubMed ID: 29885359)
1. Perception of pregnant Japanese women regarding the teratogenic risk of medication exposure during pregnancy and the effect of counseling through the Japan drug information institute in pregnancy.
Yakuwa N; Nakajima K; Koinuma S; Goto M; Suzuki T; Ito N; Watanabe O; Murashima A
Reprod Toxicol; 2018 Aug; 79():66-71. PubMed ID: 29885359
[TBL] [Abstract][Full Text] [Related]
2. Counselling pregnant women at the crossroads of Europe and Asia: effect of Teratology Information Service in Turkey.
Kaplan YC; Karadaş B; Küçüksolak G; Ediz B; Demir Ö; Sozmen K; Nordeng H
Int J Clin Pharm; 2017 Aug; 39(4):783-790. PubMed ID: 28626851
[TBL] [Abstract][Full Text] [Related]
3. Women's perception of teratogenic risk.
Koren G; Bologa M; Pastuszak A
Can J Public Health; 1991; 82(3):S11-4, S33-7. PubMed ID: 1884303
[TBL] [Abstract][Full Text] [Related]
4. The perception of teratogenic risk of cocaine.
Koren G; Gladstone D; Robeson C; Robieux I
Teratology; 1992 Dec; 46(6):567-71. PubMed ID: 1290157
[TBL] [Abstract][Full Text] [Related]
5. Counseling about medication-induced birth defects with clinical decision support in primary care.
Schwarz EB; Parisi SM; Handler SM; Koren G; Shevchik G; Fischer GS
J Womens Health (Larchmt); 2013 Oct; 22(10):817-24. PubMed ID: 23930947
[TBL] [Abstract][Full Text] [Related]
6. Women's perspectives on counseling about risks for medication-induced birth defects.
Santucci AK; Gold MA; Akers AY; Borrero S; Schwarz EB
Birth Defects Res A Clin Mol Teratol; 2010 Jan; 88(1):64-9. PubMed ID: 19637252
[TBL] [Abstract][Full Text] [Related]
7. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester.
Koren G; Bologa M; Long D; Feldman Y; Shear NH
Am J Obstet Gynecol; 1989 May; 160(5 Pt 1):1190-4. PubMed ID: 2729394
[TBL] [Abstract][Full Text] [Related]
8. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma.
Powell H; McCaffery K; Murphy VE; Hensley MJ; Clifton VL; Giles W; Gibson PG
J Asthma; 2011 Dec; 48(10):1032-40. PubMed ID: 22091740
[TBL] [Abstract][Full Text] [Related]
10. Counseling regarding pregnancy--related drug exposures by family physicians in Ontario.
Goodwin J; Rieder S; Rieder MJ; Matsui D
Can J Clin Pharmacol; 2007; 14(1):e58-69. PubMed ID: 17314415
[TBL] [Abstract][Full Text] [Related]
11. Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey.
Gils C; Pottegård A; Ennis ZN; Damkier P
BMC Pregnancy Childbirth; 2016 Aug; 16():226. PubMed ID: 27531162
[TBL] [Abstract][Full Text] [Related]
12. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
Schaefer C; Meister R; Weber-Schoendorfer C
Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
[TBL] [Abstract][Full Text] [Related]
13. Women's perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey.
Petersen I; McCrea RL; Lupattelli A; Nordeng H
BMJ Open; 2015 Jun; 5(6):e007390. PubMed ID: 26033946
[TBL] [Abstract][Full Text] [Related]
14. Perception of teratogenic risk of common medicines.
Sanz E; Gómez-López T; Martínez-Quintas MJ
Eur J Obstet Gynecol Reprod Biol; 2001 Mar; 95(1):127-31. PubMed ID: 11267734
[TBL] [Abstract][Full Text] [Related]
15. Physicians' Perception of Teratogenic Risk and Confidence in Prescribing Drugs in Pregnancy-Influence of Norwegian Drug Information Centers.
Bakkebø T; Widnes SF; Aamlid SS; Schjøtt J
Clin Ther; 2016 May; 38(5):1102-8. PubMed ID: 26973297
[TBL] [Abstract][Full Text] [Related]
16. Prescription of teratogenic medications in United States ambulatory practices.
Schwarz EB; Maselli J; Norton M; Gonzales R
Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
[TBL] [Abstract][Full Text] [Related]
18. Smoke, alcohol consumption and illicit drug use in an Italian population of pregnant women.
De Santis M; De Luca C; Mappa I; Quattrocchi T; Angelo L; Cesari E
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):106-10. PubMed ID: 21831510
[TBL] [Abstract][Full Text] [Related]
19. Prevention of unnecessary pregnancy terminations by counselling women on drug, chemical, and radiation exposure during the first trimester.
Koren G; Pastuszak A
Teratology; 1990 Jun; 41(6):657-61. PubMed ID: 2353314
[TBL] [Abstract][Full Text] [Related]
20. Teratogenicity of recently introduced medications in human pregnancy.
Lo WY; Friedman JM
Obstet Gynecol; 2002 Sep; 100(3):465-73. PubMed ID: 12220765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
